youtube_live
Q3 2026 earnings • 3:00 PM today
See detailschevron_right
SRRK:NASDAQ
Scholar Rock Holding Corp
$51.55
arrow_upward
+9.82%(+4.61) 1D
$51.99
arrow_upward
+0.85% (+0.44)bedtimeAfter hours
Closed: Nov 9, 4:00:00 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRRK...
Open
$47.90
High
$51.76
Low
$46.42
Mkt. cap
6.28B
Avg. vol.
1.66M
Volume
0.00
52-wk high
$61.75
52-wk low
$28.86
EPS
-$3.32
Beta
0.78
Shares outstanding
121.78M
No. of employees
289
Open
$47.90
High
$51.76
Low
$46.42
Mkt. cap
6.28B
Avg. vol.
1.66M
Volume
0.00
52-wk high
$61.75
52-wk low
$28.86
EPS
-$3.32
Beta
0.78
Shares outstanding
121.78M
No. of employees
289
News stories
From web sources and news partners
Benzinga
·
11 hours ago
Petrobras, TransDigm On Deck Tuesday As Oil Profits, Aerospace Demand Face Test
Investing.com
·
16 hours ago
Scholar Rock earnings loom as first Isembyld sales take focus
GuruFocus
·
16 hours ago
Scholar Rock (SRRK) Prepares to Report Q3 Earnings Amid High Pri
About Scholar Rock Holding Corp
CEO-
Employees289
Founded2012
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitescholarrock.com
Analyst ratings
Based on 16 analysts giving stock ratings to SRRK in the past 3 months
Strong buy
Buy
15
Hold
1
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for SRRK in the last 3 months.
Highest
Current $51.55
$84.00 (+62.95%)
Average
$69.67 (+35.15%)
Lowest
$58.00 (+12.51%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ritu Baral TD Cowen | Buy | Maintained | $71.00 | +37.7% | 10/21/2026 |
Allison Bratzel Piper Sandler | Buy | Maintained | $75.00 | +45.5% | 10/21/2026 |
Srikripa Devarakonda Truist Financial | Buy | Reiterated | $77.00 | +49.4% | 10/20/2026 |
Tazeen Ahmad Bank of America Securities | Buy | Maintained | - | - | 10/16/2026 |
Geoff Meacham Citi | Buy | Maintained | $74.00 | +43.5% | 10/15/2026 |
Unknown Analyst Leerink Partners | Buy | Maintained | $65.00 | +26.1% | 10/13/2026 |
Evan Seigerman BMO Capital | Buy | Reiterated | $84.00 | +62.9% | 10/12/2026 |
Etzer Darout Barclays | Hold | Maintained | $58.00 | +12.5% | 10/09/2026 |
David Nierengarten Wedbush | Buy | Maintained | $70.00 | +35.8% | 09/25/2026 |
Tessa Romero J.P. Morgan | Buy | Reiterated | $70.00 | +35.8% | 09/21/2026 |
Cory Kasimov Evercore ISI | Buy | Maintained | $72.00 | +39.7% | 09/15/2026 |
Andres Y. Maldonado H.C. Wainwright | Buy | Reiterated | $70.00 | +35.8% | 09/15/2026 |
Amy Li Jefferies | Buy | Maintained | $65.00 | +26.1% | 09/14/2026 |
Martin Auster Raymond James | Buy | Maintained | $72.00 | +39.7% | 09/14/2026 |
Michael Yee UBS | Buy | Maintained | $60.00 | +16.4% | 09/13/2026 |
Gary Nachman Canaccord Genuity | Buy | Reiterated | $62.00 | +20.3% | 08/12/2026 |
Unknown Analyst Wedbush | Buy | Maintained | $58.00 | +12.5% | 08/10/2026 |
Marc Frahm TD Cowen | Buy | Maintained | - | - | 08/09/2026 |
Unknown Analyst Canaccord Genuity | Buy | Initiated | $62.00 | +20.3% | 04/20/2026 |
Eric Schmidt FCA Cantor Fitzgerald | Buy | Maintained | - | - | 03/19/2026 |
Next call in 5:15:44
Today, 3:00 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / -$0.84
Revenue / Est. (USD)
- / 283.67K
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | - | - | - | - |
Cost of goods sold | 50.49M | 46.88M | 51.81M | 58.23M |
Cost of revenue | 50.49M | 46.88M | 51.81M | 58.23M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 53.06M | 45.02M | 50.20M | 50.67M |
Operating expense | 53.06M | 45.02M | 50.20M | 50.67M |
Total operating expenses | 103.55M | 91.90M | 102.02M | 108.90M |
Operating income | -103.55M | -91.90M | -102.02M | -108.90M |
Other non operating income | -69.00K | -61.00K | -790.00K | -570.00K |
EBT including unusual items | -102.22M | -90.96M | -105.51M | -109.90M |
EBT excluding unusual items | -102.22M | -90.96M | -102.17M | -109.90M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -102.22M | -90.96M | -105.51M | -109.90M |
Net profit margin | - | - | - | - |
Earnings per share | -0.90 | -0.88 | -0.83 | -0.84 |
Interest and investment income | 2.73M | 3.53M | 2.94M | 4.09M |
Interest expense | -1.33M | -2.53M | -2.30M | -4.52M |
Net interest expenses | 1.40M | 992.00K | 633.00K | -425.00K |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -103.13M | -91.47M | -101.68M | -108.60M |
Gain or loss from assets sale | - | - | 3.00K | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events